| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/10/2004 | WO2004075886A1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 09/10/2004 | WO2004075883A1 Use of curcumin derivatives or cape in the manufacture of a medicament for the treatment of neuroprotective disorders |
| 09/10/2004 | WO2004075882A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2004 | WO2004075879A1 Opioid delivery system |
| 09/10/2004 | WO2004075823A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | WO2004075720A2 Use of intraputaminal infused glial cell-line derived neurotrophic factor in the treatment of parkinson’s disease in humans |
| 09/10/2004 | WO2004062564A3 Sedative non-benzodiazepine formulations |
| 09/10/2004 | WO2004054957A3 Valproic acid analogues and pharmaceutical compositions thereof |
| 09/10/2004 | WO2004054565A8 Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004047854A3 Methods for the treatment of alzheimers disease and compositions therefore |
| 09/10/2004 | WO2004044204A3 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | WO2004016260A8 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003070191A3 Tamper-resistant transdermal opioid delivery devices |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | WO2002064085A3 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 09/10/2004 | CA2556629A1 Opioid delivery system |
| 09/10/2004 | CA2518675A1 Novel diazabicyclic aryl derivatives |
| 09/10/2004 | CA2516857A1 Use of intraputaminal infused glial cell-line derived neurotrophic factor in the treatment of parkinson's disease in humans |
| 09/10/2004 | CA2516660A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | CA2516618A1 Pharmaceutical composition for treatment of drug dependence |
| 09/10/2004 | CA2516579A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | CA2516563A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2004 | CA2515975A1 Peptide derivatives having .beta.-secretase inhibitory activity |
| 09/10/2004 | CA2514948A1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176591 Novel synthesis and crystallization of peperazine ring-containing compounds |
| 09/09/2004 | US20040176476 Pharmaceutical composition |
| 09/09/2004 | US20040176466 an effective amount of atomoxetine in combination with an inhibitor of Cytochrome P450s for patients who are extensive metabolizers; administering to a patient who has previously not responded to attention-deficit/hyperactivity disorder treatment |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176436 Tryptophanyl-esters and their N-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176407 Novel isoxazolopyridone derivatives and their use |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176397 (Oxo-Pyrazolo[1,5a]pyrimidin-2-yl)Alkyl-Carboxamides |
| 09/09/2004 | US20040176394 Administering heterocyclic esters such as 5-(2,4-Dimethyl-phenyl)-3-(8-hydroxy-quinolin-2-ylamino)-5-methyl-dihydro-furan-2-one for prophylaxis of headaches, sepsis, neurodegenerative diseases, or as analgesics, antiischemic or antidiabetic agents |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176388 example compound: cis-1-[(2-chloro-3-trifluoromethylphenyl)acetyl]-6-(3,4,5-trimethylpiperazin-1-yl)indole; treatment of CNS and other disorders |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176376 Pyrazolotriazines as CRF antagonists |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176364 Aryl substituted thiazinidinones and the use thereof |
| 09/09/2004 | US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors |
| 09/09/2004 | US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia |
| 09/09/2004 | US20040176333 2-Mercaptopropionamide derivatives; |
| 09/09/2004 | US20040176329 Treating Alzheimer*s, Parkinson*s, and Binswanger*s disease; antiischemic agents, dementia; nervous system, brain and neurodegenerative disorders |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176323 Pharmaceutical composition comprising lysophophatidic acid |
| 09/09/2004 | US20040176309 Siglec inhibitors |
| 09/09/2004 | US20040176270 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175698 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/09/2004 | US20040175436 synthetic zeolites and selected herbal proteins (MPP) which is applied for prevention of the development of neuropathies in persons suffering diabetes; stops the process of apoptosis caused by accumulation of Ca2+ ions in cytplasm of nerve cells |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175401 Drug delivery to the dermis mammal to improve systemic absorption |
| 09/09/2004 | US20040175396 Prophylactic agent for enhancement of nerve growth factor production for treatment or prevention comprising an aqueous mushroom extract; neurodegenerative diseases, Alzheimer*s disease, and nervous system disorders; foods, beverages, feeds |
| 09/09/2004 | US20040175390 Selection of patients with increased responsiveness to botulinum toxin |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040173224 Nicotine salts having improved taste, process for their preparation and their use |
| 09/09/2004 | DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible |
| 09/08/2004 | EP1455186A1 Screening method |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454910A1 Substituted pyrimidinyl-2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 09/08/2004 | EP1454909A1 Substituted 8'-pyridinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a) pyrimidin-6-one and 8'-pyrimidinyl-dihydrospiro-(cycloalkyl)-pyrimido(1,2-a)pyrimidin-6-one derivatives and their use against neurodegenerative diseases |
| 09/08/2004 | EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them. |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
| 09/08/2004 | EP1454627A1 Alpha-Keto carbonyl calpain inhibitors |
| 09/08/2004 | EP1454136A2 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453836A1 1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A 2a RECEPTOR ANTAGONISTS |
| 09/08/2004 | EP1453835A2 Adenosine a 2a receptor antagonists |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453831A1 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453828A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome |
| 09/08/2004 | EP1453827A1 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453815A1 Metabotropic glutamate receptor-5 modulators |